BGI Genomics Gets Green Light from CSRC for ChiNext IPO

Despite the continuous overcast and rainy weather over the past two days, today is undoubtedly an exceptionally bright day for BGI Genomics.

On the evening of June 23, the China Securities Regulatory Commission (CSRC) approved the initial public offering (IPO) applications of six companies in accordance with statutory procedures, including BGI Genomics. The company will now coordinate with its underwriters and the Shenzhen Stock Exchange to finalize the issuance schedule; listing and trading will commence following the completion of the subscription process. ChiNext: BGI is here!

Attached:

Details of BGI Genomics' Prospectus:Three Days, Three Hurdles: What Exactly Did BGI’s IPO Prospectus Reveal?